Avacopan 10mg capsules
NHS hospitals in England used £64,195,996 of indicative cost of Avacopan 10mg capsules in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 19.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Avacopan 10mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Avacopan 10mg capsules most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Imperial College Healthcare Nhs Trust | £4,647,394 |
| Derby Teaching Hospitals Nhs Found Trust | £3,567,424 |
| Cambridge Univ Hosp Nhs Foundation Trust | £3,069,866 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £2,810,098 |
| Manchester University Nhs Ft | £2,798,047 |
| Leeds Teaching Hpls Nhs Trust | £2,252,868 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,946,806 |
| Oxford University Hospitals Nhs Ft | £1,904,272 |
| University Hpls Of Leicester Nhs Trust | £1,814,180 |
| Barts Health Nhs Trust | £1,658,837 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.